PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 28 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A systematic review indicates that TCM prescriptions containing A. membranaceus var. mongholicus (found in 5.20% of assessed prescriptions) may modulate the Th17/Treg axis [PMID:32345031]
Integrative TCM therapy, where Huang-qi is a common single herb used, is associated with a reduced risk of diabetic ketoacidosis [PMID:27340102]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 35609680 (2022) — Bioactive pterocarpans from the root of Astragalus membranaceus var. mongholicus. · Phytochemistry
- 2.PMID: 32654511 (2020) — Cycloartane-type triterpenoids from the root of Astragalus membranaceus var. mongholicus. · Journal of Asian natural products research
- 3.PMID: 30691074 (2019) — Flowers of Astragalus membranaceus var. mongholicus as a Novel High Potential By-Product: Phytochemical Characterization and Antioxidant Activity. · Molecules (Basel, Switzerland)
- 4.PMID: 36244068 (2023) — Identification of characteristic markers for monofloral honey of Astragalus membranaceus var. mongholicus Hsiao: A combined untargeted and targeted MS-based study. · Food chemistry
- 5.PMID: 31890338